Washington, D.C. — House Energy and Commerce Committee Chair Cathy McMorris Rodgers (R-WA) and Subcommittee on Health Chair Brett Guthrie (R-KY) today announced a subcommittee markup of 17 bills. 

“Our committee continues to prioritize lowering health care costs, expanding access to treatments, strengthening Medicare, and bringing price transparency to patients. Additionally, we’ll discuss legislation to protect access to care in rural and underserved areas, extend programs that support workforce development, expand competition in the organ transplant network, and ensure safe and effective animal drugs for our pets and livestock. We are grateful for the amount of engagement and feedback we’re receiving from across the aisle, from the administration, and from stakeholders throughout this process and look forward to a productive subcommittee markup.” 

WHAT: A Subcommittee on Health markup of 17 bills. 

DATE: Wednesday, May 17, 2023  

TIME: 10:00 AM EDT 

LOCATION: 2123 Rayburn House Office Building 

This notice is at the direction of the Chair. The hearing will be open to the public and press and will be live streamed online at https://energycommerce.house.gov/. If you have any questions concerning the hearing, please contact Jolie Brochin with the Committee staff at Jolie.Brochin@mail.house.gov. If you have any press-related questions, please contact Christopher Krepich at Christopher.Krepich@mail.house.gov. 

Legislation to be considered: 

• H.R. 1418, the Animal Drug User Fee Amendments of 2023 (Rep. Greg Pence)  
• H.R. 2544, the Securing the U.S. Organ Procurement and Transplantation Network Act (Rep. Larry Bucshon)   
• H.R. 3281, the Transparent PRICE Act (Rep. Cathy McMorris Rodgers)   
• H.R. 2666, the Medicaid VBPs for Patients (MVP) Act (Rep. Brett Guthrie)  
• H.R. 3285, the Fairness for Patient Medications Act (Rep. Morgan Griffith)  
• H.R. 3284, the Providers and Payers COMPETE Act (Rep. Michael Burgess)  
• H.R. 3290, To amend title III of the Public Health Service Act to ensure transparency and oversight of the 340B drug discount program (Rep. Larry Bucshon)  
• H.R. 2559, the Strengthening Community Care Act of 2023 (Rep. John Joyce)   
• H.R. 2547, the Special Diabetes Program for Indians Reauthorization Act of 2023 (Rep. Tom Cole)  
• H.R. 2550, the Special Diabetes Program Reauthorization Act of 2023 (Rep. Diana DeGette)   
• H.R. 1613, the Drug Price Transparency in Medicaid Act of 2023 (Rep. Earl L. “Buddy” Carter)   
• H.R. 2665, the Supporting Safety Net Hospitals Act (Rep. Yvette D. Clarke)   
• H.R. 2679, the PBM Accountability Act (Rep. Ann Kuster)   
• H.R. 3248, the Diagnostic Lab Testing Transparency Act (Rep. Mariannette Miller-Meeks)   
• H.R. 3262, To amend title XI of the Social Security Act to increase transparency of certain health-related ownership information (Rep. Jan Schakowsky)  
• H.R. 3282, the Promoting Transparency and Healthy Competition in Medicare Act (Rep. Diana Harshbarger)  
• H.R. 3237, To amend title XVIII of the Social Security Act to require each outpatient department of a provider to include a unique identification number on claims for services, and to require hospitals with an outpatient department of a provider to submit to the Centers for Medicare & Medicaid Services an attestation with respect to each outpatient department (Rep. John Joyce)